Investors in France

LBO France is an independent company that has been supporting French and Italian companies in their growth for more than 30 years. With seasoned and diversified teams, a well-established position and in-depth knowledge of the French economy, LBO France offers management and investors of portfolio companies a wealth of experience and opportunities that spur value creation..

BRAVE FRANCE is a joint defencetech initiative between Ukraine and France. It aims to accelerate battlefield innovation by providing grants to Ukrainian and French companies developing advanced military solutions.

Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies. Keeping in mind patients’ well-being, we believe in improving medical care and taking medical innovations further ahead. We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.

Bpifrance Investissement SAS is a private equity and venture capital firm specializing in fund of funds and direct investments. For direct investments, the firm specializes in seed, series A, series B, startup, growth capital, emerging growth, early to late venture, middle market to mature stage, industry consolidation and buyout transactions in small and medium-sized companies and mid-caps. For fund of fund investments it seeks to invest in private equity funds, venture capital funds, growth capital funds, mezzanine funds, and turnaround funds, national funds, regional funds of France or in international funds with a link with France. It considers investments in the following countries: France, Germany, Switzerland, Turkey, Morocco, Australia, Japan, South Korea, New Zealand, Mexico, Canada, and the United States of America. For fund of fund investments, the firm can invest in North America, Europe including France and Italy, in North Africa including Algeria, Egypt, Morocco and Tunisia, and in Asia-pacific. It can consider investments in all sectors, some funds prefer to invest in fintech, life sciences, technology (information and communication), industrials, services, energy including nuclear and renewable energy, energetic transition, healthcare, biotechnology, robotics, big data, cloud computing, green chemistry, clothing (accessories, leather goods, shoes, home textiles), tourism, Cinema and audiovisual, video games, music and live, publishing, fashion and luxury, beauty, art and design, gastronomy and leisure sectors including Hotels and all forms of accommodation management (traditional hotels, thalassotherapy or hydrotherapy, campsites, hotel residences, reception structures, tourist residences, etc.); Catering (restaurant chains, take-out, collective catering, fast food, etc.) Leisure and free time activities (sports or leisure facilities, leisure parks, winter sports resorts, performance halls, media in the leisure part); Travel agencies/tourist transport (tour operators, excursionists, river, air transport, car rental), software, media, perfumes, cosmetics, watch making, jewellery, food and financials including private equity and real estate sectors. Generally, for direct investments, the firm can invest between $0.064 million and $240 million in firms reporting revenues between $0.56 million and $1690 million with a maximum enterprise value of $100.31 and minimum EBITDA of $4.43 million. For fund of fund investments, the firm typically invests between $1.11 million and $67.16 million. Within growth capital it seeks to invest greater than €1.5 million ($2.21 million). The firm typically invests between €0.4 million ($0.72 million) and €10 million ($13.21 million) in growth capital and leveraged buyout transactions, in companies headquartered in France with revenues starting at €5 million ($6.61 million). Its venture capital investments range between €1.5 million ($2.11 million) and €10 million ($13.21 million), which it invests in small and medium-sized companies. For fund investments, the firm invests between €3 million ($3.83 million) and €60 million ($76.66 million). It usually takes a minority stake in the companies and the funds in which it invests. Bpifrance Investissement SAS was founded in 1988 and is based in Paris, France, with additional offices located all across France. It operates as a subsidiary of Bpifrance Participations SA., The Large Cap team invests and monitors investments in companies with a strong French presence, whether listed or unlisted ISEs or large caps, with the aim of strengthening them, helping them grow, stabilising their capital or increasing their foothold in France. The large cap team makes equity or quasi-equity investments for amounts of $15 million or more, mainly through the 2020 long-term ISE fund (99 years). The large cap team makes equity or quasi-equity investments for amounts of $15 million or more, mainly through the 2020 long-term ISE fund (99 years).

M80 is a private equity firm specializing in middle market, later stage, mature, buyout, and growth capital investments. The firm primarily invests in the consumer, healthcare, business services and manufacturing sector. It does not invest in real estate, R&D based life sciences, and pre-commercial technology companies. It typically invests in companies in Belgium, the Netherlands, Luxembourg and France. The firm makes equity investments between €10 million ($12.05 million) and €60 million ($72.28 million) in companies with sales values between €25 million ($30.12 million) and €300 million ($361.4 million), an EBITDA between €5 million ($6.02 million) and €30 million ($36.14 million) and an enterprise value between €25 million ($30.12 million) and €250 million ($301.17 million). The firm prefers to have a majority stake in portfolio companies. M80 was founded in 2018 and is based in Brussels, Belgium.

MBO+ is the benchmark for all investors wishing to invest in the French lower mid-cap segment while combining performance and sustainability. Founded in 2002 as an independent management company, MBO+ has raised over €1 billion through 7 successive funds, all dedicated to private equity in SMEs valued between €20m and €200m. The firm’s primary goal is to support growing French SMEs in their development and transformation projects. MBO+ currently deploys three strategies: MBO Buyout finances growth companies with differentiating strategic advantages. MBO Flex offers entrepreneurs flexible, tailor-made solutions combining bond and equity financing to optimise financing structures while limiting capital dilution. MBO Continuation specifically supports the acceleration of the pan-European development of two high-potential companies.

We invest in seed-stage startups and focus on supporting a new generation of French entrepreneurs with global ambitions.

HCVC backs founders on a mission to industrialize scientific and technological progress, focusing on deep tech sectors including robotics, AI, biotech, and climate tech.

IPSA is a private equity and venture capital firm specializing in seed, startup, early-stage, mid venture, later stage, growth capital, and pre-IPO investments. The firm prefers to invest in life sciences, Internet, telecommunications, biotechnology, medical, energy, chemistry, information and communications technology, water purification, natural resources, cleantech, capital goods, and distribution sectors. In life science sector it further invests in clinical-stage drug development, medical devices, drug delivery, and development services. In information and communications technology sector the firm invests with a focus in content, software, enabling technology, and infrastructure. In natural resources sector it invests further in exploration and production and renewable energy and clean technology. The firm seeks to invest in companies based in European Union with a focus on France, the U.K., Germany, the Netherlands, and Denmark and it also invest occasionally in companies based in North America. It seeks to invest in the first instance between €1 million ($1.33 million) and €5 million ($6.68 million) for a minority stake in the company. It seeks to invest in companies with revenues between €10 million ($13.37 million) and €100 million ($133.73 million). The firm prefers to be the lead or a co-lead investor in its portfolio companies. It seeks to hold a board seat in its portfolio companies. The firm exits from its portfolio companies through an IPO or trade sale within five years. The firm was formerly known as Innoven Partenaires S.A. IPSA was founded in 1997 and is based in Paris, France.

ISAI, the French Tech Entrepreneurs’ fund (micro VC format), was founded by Pierre Kosciusko-Morizet, Geoffroy Roux de Bézieux, Stéphane Treppoz, and Ouriel Ohayon and is managed by Jean-David Chamboredon, Christophe Raynaud and Pierre Martini. It gathers more than 250 entrepreneurs and aims at financing and supporting high potential digital companies, at the seed/post-seed stage (venture capital) or when they have already reached the break even stage (growth capital/LBO).

Alven is an independent venture capital firm founded in 2000 by Guillaume Aubin and Charles Letourneur. Based in Paris, France, Alven has raised five funds, investing in over a hundred startups, primarily in France and the United States. The firm typically invests in 10 to 15 new companies each year. Notable investments include Se Loger, Platform.sh, Algolia, OpenClassrooms, Dataiku, Stripe, Drivy, Captain Train (acquired by Trainline), PeopleDoc (acquired by Ultimate Software), Frichti, Sezane, Marco Vasco, Qonto, Pretto, Tinyclues, Happn, Wit.ai (acquired by Facebook), Bime (acquired by Zendesk), Yubo, and Smallable. In September 2017, Alven was recognized by La Tribune as one of the three most active French funds and by CB Insights as the most active venture capital firm in France. The firm's fifth fund, Alven V, announced in January 2017, raised €200 million, marking one of the largest fundraisings in the sector at that time. Alven's team of approximately 15 professionals is located in the heart of Paris's Sentier district.

CAPZA (previously Capzanine) is an established European private investment platform focused on small & mid cap companies. The company is majority owned by its teams and supported by the AXA Group. With $2.7 billion of assets, CAPZA puts its experience and passion for investing in businesses at the service of investors in Europe and around the world. CAPZA provides a platform of 4 complementary areas of expertise: Flex Equity, Private Debt, Transition and Artemid Senior Loans.

Elaia is a leading European venture capital firm specializing in digital and deep tech startups. Founded in 2002 and headquartered in Paris, France, Elaia has a strong track record of backing tech disruptors such as Mirakl, Criteo, Ornikar, Shift Technologies, and Aqemia. The firm focuses on early-stage investments, providing capital and support to ambitious tech entrepreneurs with global ambitions. Elaia's investment areas include deep tech, sustainability, AI, data science, and big data. The firm has a history of successful exits, including companies like Criteo and Orchestra Networks. In April 2024, Elaia formed a strategic partnership with Lazard to create Lazard Elaia Capital, a technology-focused private equity investment platform. This partnership aims to support technology and deep tech leaders at all stages of their development, from seed to public markets.

Noria SAS, SCR is a private equity and venture capital firm specializing in startup, early venture, mid venture, later stage, PIPEs, recapitalization and growth capital investment. It typically invests in companies operating in the sector of renewable energy, employment and media. The firm prefers to invest mainly in France. It invest between EUR 0.5 million ($0.52 million) to EUR 15 million ($15.62 million) in equity per transaction. The firm seeks to make long-term investment while taking minority or majority stake into its portfolio companies. It also seeks to takes a seat on the management board of its investees. The firm invests through the personal capital of its management. Noria SAS, SCR is based in Lille, France, with an additional office in Tournai, Belgium and Marcq-en-Baroeul, France.

Welcome to Team8!At Team8, we aim at improving the health of kids around the world.Team8 is a connectable smart watch designed and developed for children from 5 to 12 years old.After creating its own super hero, your child will use it in many different games. Some educational games, but also games where 2 people with the watch Team8 can interact and compete.The super hero will gain energy from the behavior of the child. Physical activity, a healthy diet (yes, eating broccoli will provide more energy than a soda!), and good behavior will provide the super hero with additional powers.The built-in camera will provide information on what is best to eat, but also prevent your child from eating allergenic food. The watch will also be used to communicate with your child and as a reminder for medication. With the watch, you will always know where your child is.TRANSFORM YOUR OLD SMARTPHONE IN AFUN, HEALTHY, SECURE & EDUCATIONAL DEVICE FOR YOUR KIDSGROW, EVERY DAYAdopting good reflex is above all a question of habitCREATE YOUR CHARACTERTemplate, shapes, colors ... create your super-hero in your image and launch into the adventure!GIVE HIM YOUR ENERGYMove and get energy you'll be able to transfer to your superheroPLAY WITH YOUR CHARACTEREvolve your character through many games, thanks to the energy that you will have transmitted to himSTRENGTHEN YOUR CHARACTERCollect points over games to evolve your character and see him growSTRENGTHEN YOUR CIRCLE OF FRIENDSInvite your friends and their superheroes to join you in this adventure!

The aim of Scientipole Initiative is to closely associate corporate and technological resources in order to contribute to the emergence of innovative enterprises and support the development of such projects. Scientipole Initiative audits the potential projects, counsels and accompanies the future entrepreneurs from both a scientific and technological base as well as from a managerial point of view. The granting of a non-guaranteed no-interest loan to the principal entrepreneur(s) of the start-up or project furnishes a real tool of financial leverage. This

Xerys invests in companies that are at the forefront of technology innovation in their industry, with a clearly defined strategy, supporting management teams and entrepreneurs who demonstrate passion, deep industry experience, and a long-standing commitment to their business. We look for well-articulated projects showing an ambitious, yet realistic course towards sustainable value creation, and provide the financial resources, industry networks and management expertise needed to further expand the business.

Abénex supports the growth and transformation projects of SMEs and mid-cap companies alongside their managers and their teams. A pioneer in this business in France, Abénex has recognized know-how in capital development and transfer capital operations. Abénex is keen to undertake business and has also developed an activity that delivers turnkey projects for investment in productive real estate assets.

Capgemini Engineering, formerly known as Altran Technologies, is a global innovation and engineering consulting firm founded in 1982 in France by Alexis Kniazeff and Hubert Martigny. The company specializes in high-technology and innovation industries, with a strong focus on electronics and IT technology. In 2018, Capgemini Engineering reported revenues of €2.916 billion and employed over 46,693 people worldwide. In April 2020, Capgemini Engineering became a subsidiary of Capgemini following a friendly takeover, and was renamed Capgemini Engineering on April 8, 2021, after merging with Capgemini's Engineering and R&D services.

Apheon is a private equity firm specializing in buyout, International expansion, add-on acquisitions, carve-out and industry consolidation investments in lower middle market and mature companies. The firm prefers to invest in niche industrials, healthcare, consumer, services and media. It seeks to invest in Europe, Andorra, Gibraltar, Luxembourg, Netherlands, Iberia, Spain, Portugal, Germany, Switzerland, Italy, Benelux, and France. It typically invests between €10 million ($11.71 million) and €75 million ($87.86 million) in companies having EBITDA between €10 million ($11.71 million) and €60 million ($70.28 million), Enterprise Value upto €300 million ($351.44 million) and turnover between €20 million ($23.42 million) and €100 million ($117.14 million). The firm prefers to take majority stake in portfolio companies. Apheon was founded in 2005 and is headquartered in Luxembourg City, Luxembourg, with additional offices in Europe.

Astorg is a global private equity firm with €13 billion of assets under management. With offices in London, Paris, New York, Milan, Frankfurt and Luxembourg, Astorg's investment team comprises of 66 professionals. Creating value starts with a clear investment strategy, supported by a disciplined investment process. Our investment process ensures we fully understand the strength of the strategic fundamentals of the companies we invest in, and chart the right path for future value creation. We get this understanding from our ability to carefully listen to founders and management teams of businesses we are interested in, and from the uncompromising market research that we conduct in parallel. We can then move quickly, thanks to simple, local decision making. The success of the Astorg process is shown by the long-term value we have created over the last 20 years. And it’s only when we understand what the goals and ambitions of management teams are that we act. We want to invest alongside business leaders driven by a long-term vision and aware of the high cost of capital. Our involvement as shareholders is to ensure that the right human resources are deployed, that capital employment is optimised and that a clear strategic roadmap is executed. We concentrate on deals where we can develop a competitive advantage – this can come from our in-depth knowledge of a sector or industry or our ability to deliver a complex transaction. And by focusing on a limited number of companies per fund we can: Share our experience to optimise key performance drivers Identify, unlock and execute complementary acquisitionsActively participate in key strategic decisionsInitiate and support performance improvement initiatives Support the management team as needed

Axeleo Capital is a multi-strategy tech investment platform backing Europe's leaders in digital and green transformation, providing Seed to Series B investments with a hands-on, founder-first approach.

Breega is a European venture capital fund designed to finance startups in the digital economy. The fund, comprised of experienced investors with entrepreneurial experience, exercises an approach to financing that includes providing on-the-ground support to its startups by an in-house team of specialists focused on providing sectorial and operational expertise. Leading the way in transforming the modern VC, Breega invests in Seed and Series Arounds, up to 10M$.

Cenitz is a private equity firm specializing in from seed to series A, early-stage startups. The firm prefers to invest in Class II and III Medical Devices, Digital Health Solutions, AI-related softwares and DTx. The firm seek to invest in European Startups. The firm's minimum Ticket size €25k ($0.02704 million) Cenitz is headquartered in Neuilly-sur-Seine, France.

Ciclad is a historic private equity player in France with over 35 years of experience, specializing in high-growth SMEs through transmission and development operations across all sectors.